Ovid Therapeutics (OVID) Other Working Capital Changes (2016 - 2026)
Ovid Therapeutics (OVID) posted Other Working Capital Changes of -$349000.0 for Q1 2026, down 2.05% on a QoQ basis from -$342000.0 in Q4 2025, and down 7.38% year-over-year from -$376827.2 in Q1 2025.
Ovid Therapeutics (OVID) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Ovid Therapeutics' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$349000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 7.38% year-over-year to -$349000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (down 7.26% YoY) and the FY2025 annual result came in at -$1.3 million, down 7.22% from the prior year.
- Other Working Capital Changes was -$349000.0 for Q1 2026 at Ovid Therapeutics, down from -$342000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.3 million in Q2 2023 and bottomed at -$1.8 million in Q3 2023.
- A 5-year average of $121688.7 and a median of -$151000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes slumped 224.75% — and 2024, when it surged 61.28%.
- Ovid Therapeutics' Other Working Capital Changes stood at $286838.0 in 2022, then slumped by 203.19% to -$296000.0 in 2023, then dropped by 8.11% to -$320000.0 in 2024, then declined by 6.88% to -$342000.0 in 2025, then slipped by 2.05% to -$349000.0 in 2026.
- Business Quant data shows OVID's Other Working Capital Changes at -$349000.0 in Q1 2026, -$342000.0 in Q4 2025, and -$337000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -110,000.00 |
| Mar 31, 2026 | -110,000.00 |
| Mar 31, 2026 | -110,000.00 |
| Dec 31, 2025 | 1.08 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | -160,000.00 |
| Sep 30, 2025 | -160,000.00 |
| Sep 30, 2025 | -160,000.00 |
| Jun 30, 2025 | 818,000.00 |
| Jun 30, 2025 | 818,000.00 |
| Jun 30, 2025 | 818,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | -899,000.00 |
| Dec 31, 2024 | -899,000.00 |
| Dec 31, 2024 | -899,000.00 |
| Sep 30, 2024 | -151,000.00 |
| Sep 30, 2024 | -151,000.00 |